Watch the full video on YouTube - https://www.youtube.com/watch?v=tC9DGL559lg&t=1138s
Susanne has held positions of increasing seniority across a range of business areas during her career at Novartis, having first joined the company as a sales representative in Germany in 1995. The majority of her roles have been in oncology, where she has a passion for making a difference in the lives of patients. Prior to her current position, she served as President of Advanced Accelerator Applications, a Novartis company focused on the development of products for targeted radioligand therapy and precision imaging. Today, she leads more than 10 000 employees in 85 countries working to transform cancer care across four distinct therapeutic platforms.
Susanne is a respected business leader and scientist who was featured in Fortune’s “Most Powerful Women International” list in both 2019 and 2020. She actively mentors women at Novartis and encourages them to seek leadership roles.
Susanne has a background in science and holds a doctorate in organic chemistry from the University of Erlangen in Germany, but as a former ballet dancer, she is also passionate about the arts. This dual interest informs her leadership philosophy, which celebrates diversity of thought and ideas as one of the keys to bold innovation.
Susanne also holds leadership positions in the broader pharmaceutical industry. She serves on the board and executive committee of the European Federation of Pharmaceutical Industries and Associations (EFPIA), and is vice chair of EFPIA’s Patient Access Committee.
Susanne on LinkedIn: https://www.linkedin.com/in/susanne-s...
Subscribe to our newsletter for more insights.
Further reading
-
Announcement
Slow, slow, quick-quick, slow
The fallout from the recent FDA conditional approval of Aduhelm (aducanumab) for the treatment of Alzheimer’s disease has reignited the debate on the place of accelerated drug approval.
-
Announcement
Gene Therapy: Can it have therapeutic applications beyond rare diseases?
Over the past decade, cell and gene therapies have made incredible clinical progress- begging the question: How far can gene therapies go?
